Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith K Chuk

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Challenges in Opening and Enrolling Patients in Clinical TrialsJulie M Vose, Meredith K Chuk, Francis Giles
The Oncologist|August 18, 2009
TrabectedinMeredith K Chuk, Frank M Balis, Elizabeth Fox
Blood|May 5, 2009
Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twinMeredith K Chuk, Emily McIntyre, Donald Small, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational AgentsMeredith K Chuk, Yeruk Mulugeta, Michelle Roth-Cline, et al.
Pediatric Blood & Cancer|July 20, 2007
Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patientsSu Young Kim, Alix A Dabb, Donald J Glenn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2017
FDA Approval Summary: Eribulin for Patients with Unresectable or Metastatic Liposarcoma Who Have Received a Prior Anthracycline-Containing RegimenChristy L Osgood, Meredith K Chuk, Marc R Theoret, et al.
Pediatric Blood & Cancer|August 1, 2012
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumorsMeredith K Chuk, Alberta Aikin, Trish Whitcomb, et al.
Journal of the National Cancer Institute|August 29, 2020
Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer TrialsPaul G Kluetz, Bellinda L King-Kallimanis, Daniel Suzman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Expansion Cohorts in First-in-Human Solid Tumor Oncology TrialsMarc R Theoret, Lee H Pai-Scherf, Meredith K Chuk, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2010
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate modelMeredith K Chuk, Diane E Cole, Cynthia McCully, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 1, 2017
Challenges in Opening and Enrolling Patients in Clinical TrialsJulie M Vose, Meredith K Chuk, Francis Giles
The Oncologist|August 18, 2009
TrabectedinMeredith K Chuk, Frank M Balis, Elizabeth Fox
Blood|May 5, 2009
Discordance of MLL-rearranged (MLL-R) infant acute lymphoblastic leukemia in monozygotic twins with spontaneous clearance of preleukemic clone in unaffected twinMeredith K Chuk, Emily McIntyre, Donald Small, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 1, 2016
Enrolling Adolescents in Disease/Target-Appropriate Adult Oncology Clinical Trials of Investigational AgentsMeredith K Chuk, Yeruk Mulugeta, Michelle Roth-Cline, et al.
Pediatric Blood & Cancer|July 20, 2007
Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patientsSu Young Kim, Alix A Dabb, Donald J Glenn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2017
FDA Approval Summary: Eribulin for Patients with Unresectable or Metastatic Liposarcoma Who Have Received a Prior Anthracycline-Containing RegimenChristy L Osgood, Meredith K Chuk, Marc R Theoret, et al.
Pediatric Blood & Cancer|August 1, 2012
A phase I trial and pharmacokinetic study of a 24-hour infusion of trabectedin (Yondelis®, ET-743) in children and adolescents with relapsed or refractory solid tumorsMeredith K Chuk, Alberta Aikin, Trish Whitcomb, et al.
Journal of the National Cancer Institute|August 29, 2020
Advancing Assessment, Analysis, and Reporting of Safety and Tolerability in Cancer TrialsPaul G Kluetz, Bellinda L King-Kallimanis, Daniel Suzman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2015
Expansion Cohorts in First-in-Human Solid Tumor Oncology TrialsMarc R Theoret, Lee H Pai-Scherf, Meredith K Chuk, et al.
Cancer Chemotherapy and Pharmacology|August 21, 2010
Plasma and CNS pharmacokinetics of O4-benzylfolic acid (O4BF) and metabolite in a non-human primate modelMeredith K Chuk, Diane E Cole, Cynthia McCully, et al.
Pageof 2